Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms
“It’s never been more clear that we are delivering exactly what millions of people have been waiting for,” said HIMS CEO Andrew Dudum after Q2 results investors.hims.com. With analysts ranging from “Sell”